The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
The Role of Natural Killer Cells in Autoimmune Diseases
Open accessAbstract
Natural killer (NK) cells, the large granular lymphocytes differentiated from the common lymphoid progenitors, were discovered in early 1970’s. They are members of innate immunity and were initially defined by their strong cytotoxicity against virus-infected cells and by their important effector functions in anti-tumoral immune responses. Nowadays, NK cells are classified among the recently discovered innate lymphoid cell subsets and have capacity to influence both innate and adaptive immune responses. Therefore, they can be considered as innate immune cells that stands between the innate and adaptive arms of immunity. NK cells don’t express T or B cell receptors and are recognized by absence of CD3. There are two major subgroups of NK cells according to their differential expression of CD16 and CD56. While CD16+CD56 dim subset is best-known by their cytotoxic functions, CD16-CD56 bright NK cell subset produces a bunch of cytokines comparable to CD4+T helper cell subsets. Another subset of NK cells with production of interleukin (IL)-10 was named as NK regulatory cells, which has suppressive properties and could take part in immune-regulatory responses. Activation of NK cells is determined by a delicate balance of cell-surface receptors that have either activating or inhibitory properties. On the other hand, a variety of cytokines including IL-2, IL-12, IL-15, and IL-18 influence NK cell activity. NK-derived cytokines and their cytotoxic functions through induction of apoptosis take part in regulation of the immune responses and could contribute to the pathogenesis of many immune mediated diseases including ankylosing spondylitis, Behçet’s disease, multiple sclerosis, rheumatoid arthritis, psoriasis, systemic lupus erythematosus and type-1 diabetes. Dysregulation of NK cells in autoimmune disorders may occur through multiple mechanisms. Thanks to the rapid developments in biotechnology, progressive research in immunology enables better characterization of cells and their delicate roles in the complex network of immunity. As NK cells stand in between innate and adaptive arms of immunity and “bridge” them, their contribution in inflammation and immune regulation deserves intense investigations. Better understanding of NK-cell biology and their contribution in both exacerbation and regulation of inflammatory disorders is a requisite for possible utilization of these multi-faceted cells in novel therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
Iyer, S. S., & Cheng, G. (2012) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v32.i1.30 · Cited by 1,611
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Kiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143
Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells
Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., & Trinchieri, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010938 · Cited by 1,028
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
CD56bright natural killer (NK) cells: an important NK cell subset
Poli, A., Michel, T., Thérésine, M., Andrès, E., Hentges, F., & Zimmer, J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03027.x · Cited by 977
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors
Braun, J., Bollow, M., Remlinger, G., Eggens, U., Rudwaleit, M., Distler, A., & Sieper, J. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1<58::aid-art8>3.0.co;2-g · Cited by 933
Kukurba, K. R., & Montgomery, S. B. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top084970 · Cited by 924
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 848
The immune cell landscape in kidneys of patients with lupus nephritis
the Accelerating Medicines Partnership in SLE network, Arazi, A., Rao, D. A., Berthier, C. C., Davidson, A., Liu, Y., Hoover, P. J., Chicoine, A., Eisenhaure, T. M., Jonsson, A. H., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0398-x · Cited by 827
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H., Chiang, S. C. C., Foley, B., Mattsson, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.008 · Cited by 787
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Activation of NK cell cytotoxicity
Smyth, M. J., Cretney, E., Kelly, J. M., Westwood, J. A., Street, S. E. A., Yagita, H., Takeda, K., Dommelen, S. L. H. V., Degli-Esposti, M. A., & Hayakawa, Y. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.034 · Cited by 714
Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells
Piccioli, D., Sbrana, S., Melandri, E., & Valiante, N. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010934 · Cited by 701
Life and death by death receptors
Guicciardi, M. E., & Gores, G. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-111005 · Cited by 690
Remmers, E. F., Cosan, F., Kirino, Y., Ombrello, M. J., Abaci, N., Satorius, C., Le, J. M., Yang, B., Korman, B. D., Cakiris, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.625 · Cited by 681
RNA‐Seq methods for transcriptome analysis
Hrdlickova, R., Toloue, M., & Tian, B. (2017) · WIREs RNA · doi:10.1002/wrna.1364 · Cited by 679
DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes
Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)70060-4 · Cited by 641
Natural-killer cells and dendritic cells: “l'union fait la force”
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005) · Blood · doi:10.1182/blood-2005-03-1154 · Cited by 634
Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis
Clynes, R., Dumitru, C., & Ravetch, J. V. (1998) · Science · doi:10.1126/science.279.5353.1052 · Cited by 625
NKG2D Receptor and Its Ligands in Host Defense
Lanier, L. L. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0098 · Cited by 599 · cited 2×
“Tumors could escape from the host immune system by shedding of NKG2D ligands from tumor cells (62, 63).”
BackgroundBielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A., & Martin, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601335103 · Cited by 597
Multiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580
Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., & Perussia, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2375 · Cited by 566
Development, Differentiation, and Diversity of Innate Lymphoid Cells
Diefenbach, A., Colonna, M., & Koyasu, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.005 · Cited by 560
Kirino, Y., Bertsias, G., Ishigatsubo, Y., Mizuki, N., Tugal-Tutkun, I., Seyahi, E., Ozyazgan, Y., Sacli, F. S., Erer, B., Inoko, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2520 · Cited by 556
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Sivori, S., Vacca, P., Del Zotto, G., Munari, E., Mingari, M. C., & Moretta, L. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0206-4 · Cited by 555
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
Degli-Esposti, M. A., & Smyth, M. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1549 · Cited by 554
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Regulation of immune cell function and differentiation by the NKG2D receptor
Zafirova, B., Wensveen, F. M., Gulin, M., & Polić, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0797-0 · Cited by 538
Mizuki, N., Meguro, A., Ota, M., Ohno, S., Shiota, T., Kawagoe, T., Ito, N., Kera, J., Okada, E., Yatsu, K., et al. (2010) · Nature Genetics · doi:10.1038/ng.624 · Cited by 526
Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
Juo, P., Kuo, C. J., Yuan, J., & Blenis, J. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00420-4 · Cited by 526
Regulation of interferon-γ production by IL-12 and IL-18
Okamura, H., Kashiwamura, S.-I., Tsutsui, H., Yoshimoto, T., & Nakanishi, K. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80163-5 · Cited by 523
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
Human natural killer cell development and biology
Farag, S. S., & Caligiuri, M. A. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.10.001 · Cited by 506
Groh, V., Brühl, A., El-Gabalawy, H., Nelson, J. L., & Spies, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632807100 · Cited by 506
Romagnani, C., Juelke, K., Falco, M., Morandi, B., D’Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4947 · Cited by 494
Apoptosome: a platform for the activation of initiator caspases
Bao, Q., & Shi, Y. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402028 · Cited by 466
Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070695 · Cited by 455
Role of Th17 cells in human autoimmune arthritis
Leipe, J., Grunke, M., Dechant, C., Reindl, C., Kerzendorf, U., Schulze‐Koops, H., & Skapenko, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27622 · Cited by 448
NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Evidence for discrete stages of human natural killer cell differentiation in vivo
Freud, A. G., Yokohama, A., Becknell, B., Lee, M. T., Mao, H. C., Ferketich, A. K., & Caligiuri, M. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052507 · Cited by 443
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Gauthier, L., Morel, A., Anceriz, N., Rossi, B., Blanchard-Alvarez, A., Grondin, G., Trichard, S., Cesari, C., Sapet, M., Bosco, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.041 · Cited by 439
Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1656::aid-immu1656>3.0.co;2-1 · Cited by 422
Romas, E., Gillespie, M. T., & Martin, T. J. (2002) · Bone · doi:10.1016/s8756-3282(01)00682-2 · Cited by 411
A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells
Freud, A. G., Becknell, B., Roychowdhury, S., Mao, H. C., Ferketich, A. K., Nuovo, G. J., Hughes, T. L., Marburger, T. B., Sung, J., Baiocchi, R. A., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.013 · Cited by 401
Human CD56bright NK Cells: An Update
Michel, T., Poli, A., Cuapio, A., Briquemont, B., Iserentant, G., Ollert, M., & Zimmer, J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502570 · Cited by 395
NK cells at the interface between innate and adaptive immunity
Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., & Moretta, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402170 · Cited by 387
Location and cellular stages of natural killer cell development
Yu, J., Freud, A. G., & Caligiuri, M. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.07.005 · Cited by 387
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T., Punaro, M., Bolland, S., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
Stephenson, W., Donlin, L. T., Butler, A., Rozo, C., Bracken, B., Rashidfarrokhi, A., Goodman, S. M., Ivashkiv, L. B., Bykerk, V. P., Orange, D. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02659-x · Cited by 365
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B.-N., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364
The Yin and Yang of HLA and KIR in human disease
Kulkarni, S., Martin, M. P., & Carrington, M. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.06.003 · Cited by 363
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
FITZGERALDBOCARSLY, P., DAI, J., & SINGH, S. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.006 · Cited by 351
Barry, M., Heibein, J. A., Pinkoski, M. J., Lee, S.-F., Moyer, R. W., Green, D. R., & Bleackley, R. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3781-3794.2000 · Cited by 345
De Maria, A., Bozzano, F., Cantoni, C., & Moretta, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012356108 · Cited by 344
IL-15 is an essential mediator of peripheral NK-cell homeostasis
Ranson, T., Vosshenrich, C. A. J., Corcuff, E., Richard, O., Müller, W., & Di Santo, J. P. (2003) · Blood · doi:10.1182/blood-2002-11-3392 · Cited by 342
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Role of the innate immune system in the pathogenesis of multiple sclerosis
Gandhi, R., Laroni, A., & Weiner, H. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.10.015 · Cited by 331
Interleukin-2, Interleukin-15, and Their Roles in Human Natural Killer Cells
Becknell, B., & Caligiuri, M. A. (2005) · Advances in Immunology · doi:10.1016/s0065-2776(04)86006-1 · Cited by 325
Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L. D., Moretta, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.235 · Cited by 310
Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones
Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A., & Long, E. O. (1995) · Science · doi:10.1126/science.7863326 · Cited by 309
Cortes, A., Pulit, S. L., Leo, P. J., Pointon, J. J., Robinson, P. C., Weisman, M. H., Ward, M., Gensler, L. S., Zhou, X., Garchon, H.-J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8146 · Cited by 306
Yang, C., Siebert, J. R., Burns, R., Gerbec, Z. J., Bonacci, B., Rymaszewski, A., Rau, M., Riese, M. J., Rao, S., Carlson, K.-S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11947-7 · Cited by 304
Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., & Santoni, A. (2007) · Blood · doi:10.1182/blood-2006-10-052720 · Cited by 297
'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
McGonagle, D., Aydin, S. Z., Gül, A., Mahr, A., & Direskeneli, H. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.147 · Cited by 292
Gold, R., Giovannoni, G., Selmaj, K., Havrdova, E., Montalban, X., Radue, E.-W., Stefoski, D., Robinson, R., Riester, K., Rana, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62190-4 · Cited by 287
Behçet's syndrome: disease manifestations, management, and advances in treatment
Yazici, H., Fresko, I., & Yurdakul, S. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0436 · Cited by 285
Huang, D., Shi, F., Jung, S., Pien, G. C., Wang, J., Salazar‐Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H., Biron, C. A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5465com · Cited by 284
Surface NK receptors and their ligands on tumor cells
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., & Moretta, A. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.002 · Cited by 283
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Impairment of NK Cell Function by NKG2D Modulation in NOD Mice
Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T., Carnaud, C., Bluestone, J. A., & Lanier, L. L. (2003) · Immunity · doi:10.1016/s1074-7613(02)00505-8 · Cited by 276
Nelson, G. W., Martin, M. P., Gladman, D., Wade, J., Trowsdale, J., & Carrington, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4273 · Cited by 276
Regulatory NK Cells Suppress Antigen-Specific T Cell Responses
Deniz, G., Erten, G., Kücüksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A., & Akdis, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.850 · Cited by 256
Self-citationNeuronal damage in brain inflammation
Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., & Zipp, F. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.185 · Cited by 249
Yu, H., Fehniger, T. A., Fuchshuber, P., Thiel, K. S., Vivier, E., Carson, W. E., & Caligiuri, M. A. (1998) · Blood · doi:10.1182/blood.v92.10.3647 · Cited by 237
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset
Mace, E. M., Hsu, A. P., Monaco-Shawver, L., Makedonas, G., Rosen, J. B., Dropulic, L., Cohen, J. I., Frenkel, E. P., Bagwell, J. C., Sullivan, J. L., et al. (2013) · Blood · doi:10.1182/blood-2012-09-453969 · Cited by 233
Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
Ochoa, M. C., Minute, L., Rodriguez, I., Garasa, S., Perez‐Ruiz, E., Inogés, S., Melero, I., & Berraondo, P. (2017) · Immunology & Cell Biology · doi:10.1038/icb.2017.6 · Cited by 230
Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
Pross, H. F., & Jondal, M. (1975) · PubMed · Cited by 229
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Identification of NKp80, a novel triggering molecule expressed by human NK cells
Vitale, M., Falco, M., Castriconi, R., Parolini, S., Zambello, R., Semenzato, G., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<233::aid-immu233>3.0.co;2-4 · Cited by 223
Target cell defense prevents the development of diabetes after viral infection
Flodström, M., Maday, A., Balakrishna, D., Cleary, M. M., Yoshimura, A., & Sarvetnick, N. (2002) · Nature Immunology · doi:10.1038/ni771 · Cited by 220
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function
Montaldo, E., Zotto, G. D., Chiesa, M. D., Mingari, M. C., Moretta, A., Maria, A. D., & Moretta, L. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22302 · Cited by 218
Inflammatory markers in systemic lupus erythematosus
Aringer, M. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102374 · Cited by 215
Death receptor signals to the mitochondria
Khosravi-Far, R. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1173 · Cited by 214
Perforin: an important player in immune response
Osińska, I., Popko, K., & Demkow, U. (2014) · Central European Journal of Immunology · doi:10.5114/ceji.2014.42135 · Cited by 214
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis
Mistry, P., & Kaplan, M. J. (2017) · Clinical Immunology · doi:10.1016/j.clim.2016.08.010 · Cited by 213
Disturbances of apoptotic cell clearance in systemic lupus erythematosus
Shao, W.-H., & Cohen, P. L. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3206 · Cited by 212
A subset of natural killer cells is greatly expanded within inflamed joints
Dalbeth, N., & Callan, M. F. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10410 · Cited by 210
Innate immunity drives pathogenesis of rheumatoid arthritis
Edilova, M. I., Akram, A., & Abdul-Sater, A. A. (2021) · Biomedical Journal · doi:10.1016/j.bj.2020.06.010 · Cited by 210
Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing
Smith, S. L., Kennedy, P. R., Stacey, K. B., Worboys, J. D., Yarwood, A., Seo, S., Solloa, E. H., Mistretta, B., Chatterjee, S. S., Gunaratne, P., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000699 · Cited by 205
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus
Park, Y., Kee, S., Cho, Y., Lee, E., Lee, H., Kim, E., Shin, M., Park, J., Kim, T., Lee, S., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24556 · Cited by 204
Development of innate lymphoid cells
Zook, E. C., & Kee, B. L. (2016) · Nature Immunology · doi:10.1038/ni.3481 · Cited by 204
Innate Immune Cells' Contribution to Systemic Lupus Erythematosus
Herrada, A. A., Escobedo, N., Iruretagoyena, M., Valenzuela, R. A., Burgos, P. I., Cuitino, L., & Llanos, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00772 · Cited by 202
Vitale, M., Chiesa, M. D., Carlomagno, S., Romagnani, C., Thiel, A., Moretta, L., & Moretta, A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425100 · Cited by 197
Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12.
Warren, H. S., Kinnear, B. F., Phillips, J. H., & Lanier, L. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5144 · Cited by 196
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis
Söderström, K., Stein, E., Colmenero, P., Purath, U., Müller-Ladner, U., Teixeira de Matos, C., Tarner, I. H., Robinson, W. H., & Engleman, E. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000546107 · Cited by 196
Chen, L., & Tsai, T.-F. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16083 · Cited by 187
Innate lymphoid cells in allergic and nonallergic inflammation
Morita, H., Moro, K., & Koyasu, S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.011 · Cited by 186
Gross, C. C., Schulte-Mecklenbeck, A., Rünzi, A., Kuhlmann, T., Posevitz-Fejfár, A., Schwab, N., Schneider-Hohendorf, T., Herich, S., Held, K., Konjević, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524924113 · Cited by 180
To die or not to die—the quest of the TRAIL receptors
Degli‐Esposti, M. A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.5.535 · Cited by 178
Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
Jiang, W., Chai, N. R., Maric, D., & Bielekova, B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100789 · Cited by 173
Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity
Poirot, L., Benoist, C., & Mathis, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402065101 · Cited by 173
Mechanisms of Allergen-Specific Immunotherapy and Allergen Tolerance
Kucuksezer, U. C., Ozdemir, C., Cevhertas, L., Ogulur, I., Akdis, M., & Akdis, C. A. (2020) · Allergology International · doi:10.1016/j.alit.2020.08.002 · Cited by 173
Self-citationProduction of IL-10 by Human Natural Killer Cells Stimulated with IL-2 and/or IL-12
Mehrotra, P. T., Donnelly, R. P., Wong, S., Kanegane, H., Geremew, A., Mostowski, H. S., Furuke, K., Siegel, J. P., & Bloom, E. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2637 · Cited by 172
Nielsen, N., Ødum, N., Ursø, B., Lanier, L. L., & Spee, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031959 · Cited by 172
Recognition and Regulation of T Cells by NK Cells
Pallmer, K., & Oxenius, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00251 · Cited by 172
Lange, U., Teichmann, J., Müller-Ladner, U., & Strunk, J. (2005) · Rheumatology · doi:10.1093/rheumatology/kei082 · Cited by 171
Grzywacz, B. J., Kataria, N., Sikora, M., Oostendorp, R. A. J., Dzierzak, E. A., Blazar, B. R., Miller, J. S., & Verneris, M. R. (2006) · Blood · doi:10.1182/blood-2006-04-020198 · Cited by 169
Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells
Rydyznski, C. E., Daniels, K. A., Karmele, E. P., Brooks, T., Mahl, S. E., Moran, M. T., Li, C., Sutiwisesak, R., Welsh, R. M., & Waggoner, S. N. (2015) · Nature Communications · doi:10.1038/ncomms7375 · Cited by 169
Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
Benczur, M., Petrányl, G. G., Pálffy, G., Varga, M., Tálas, M., Kotsy, B., Földeş, I., & Hollán, S. R. (1980) · PubMed Central · Cited by 165
Pathogenesis of Behçet’s disease: autoinflammatory features and beyond
Gül, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0502-8 · Cited by 164
Altered Natural Killer Cells in Type 1 Diabetic Patients
Rodacki, M., Svoren, B., Butty, V., Besse, W., Laffel, L., Benoist, C., & Mathis, D. (2007) · Diabetes · doi:10.2337/db06-0493 · Cited by 163
Cytotoxic T Lymphocyte-assisted Suicide
Atkinson, E. A., Barry, M., Darmon, A. J., Shostak, I., Turner, P., Moyer, R. W., & Bleackley, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21261 · Cited by 161
Kirino, Y., Zhou, Q., Ishigatsubo, Y., Mizuki, N., Tugal-Tutkun, I., Seyahi, E., Özyazgan, Y., Ugurlu, S., Erer, B., Abaci, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306352110 · Cited by 161
Viruses and Multiple Sclerosis
Oskari Virtanen, J., & Jacobson, S. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661220 · Cited by 161
Renoux, V. M., Zriwil, A., Peitzsch, C., Michaëlsson, J., Friberg, D., Soneji, S., & Sitnicka, E. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.011 · Cited by 160
Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells
Scoville, S. D., Freud, A. G., & Caligiuri, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00360 · Cited by 160
Ombrello, M. J., Kirino, Y., de Bakker, P. I. W., Gül, A., Kastner, D. L., & Remmers, E. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406575111 · Cited by 159
Olsson, T. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90135-8 · Cited by 158
Natural killer cells in human autoimmune disorders
Fogel, L., Yokoyama, W., & French, A. R. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4232 · Cited by 156
Next-generation sequencing identifies the natural killer cell microRNA transcriptome
Fehniger, T. A., Wylie, T., Germino, E., Leong, J. W., Magrini, V. J., Koul, S., Keppel, C. R., Schneider, S. E., Koboldt, D. C., Sullivan, R. P., et al. (2010) · Genome Research · doi:10.1101/gr.107995.110 · Cited by 156
Łuszczek, W., Mańczak, M., Cisło, M., Nockowski, P., Wiśniewski, A., Jasek, M., & Kuśnierczyk, P. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.05.008 · Cited by 155
T-bet and Eomesodermin in NK Cell Development, Maturation, and Function
Simonetta, F., Pradier, A., & Roosnek, E. E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00241 · Cited by 149
Role of Distinct Natural Killer Cell Subsets in Anticancer Response
Stabile, H., Fionda, C., Gismondi, A., & Santoni, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00293 · Cited by 149
Morandi, F., Horenstein, A. L., Chillemi, A., Quarona, V., Chiesa, S., Imperatori, A. S., Zanellato, S., Mortara, L., Gattorno, M., Pistoia, V., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500591 · Cited by 145
Hervier, B., Béziat, V., Haroche, J., Mathian, A., Lebon, P., Ghillani‐Dalbin, P., Musset, L., Debré, P., Amoura, Z., & Vieillard, V. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30313 · Cited by 144
Loza, M. J., Zamai, L., Azzoni, L., Rosati, E., & PERUSSIA, B. (2002) · Blood · doi:10.1182/blood.v99.4.1273 · Cited by 142
Saraste, M., Irjala, H., & Airas, L. M. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0803-3 · Cited by 140
Granzyme‐positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue
Tak, P. P., Kummer, J. A., Hack, C. E., Daha, M. R., Smeets, T. J. M., Erkelens, G. W., Meinders, A. E., Kluin, P. M., & Breedveld, F. C. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371205 · Cited by 140
NKp80 Defines a Critical Step during Human Natural Killer Cell Development
Freud, A. G., Keller, K. A., Scoville, S. D., Mundy-Bosse, B. L., Cheng, S., Youssef, Y., Hughes, T. L., Zhang, X., Mo, X. M., Porcu, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.095 · Cited by 140
Bennett, I. M., Zatsepina, O. G., Zamai, L., Azzoni, L., Mikheeva, T., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1845 · Cited by 139
McVay (1996) · doi:10.1084/jem.184.4.1585 · Cited by 138
Ciccia, F., Accardo-Palumbo, A., Alessandro, R., Rizzo, A. G., Principe, S., Peralta, S., Raiata, F., Giardina, A. R., Leo, G. D., & Triolo, G. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34355 · Cited by 135
Vitale, M., Castriconi, R., Parolini, S., Pende, D., Hsu, M. L., Moretta, L., Cosman, D., & Moretta, A. (1999) · International Immunology · doi:10.1093/intimm/11.1.29 · Cited by 134
NK Cells and Their Ability to Modulate T Cells during Virus Infections
Cook, K. D., Waggoner, S. N., & Whitmire, J. K. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010604 · Cited by 133
Eloranta, M., Lövgren, T., Finke, D., Mathsson, L., Rönnelid, J., Kastner, B., Alm, G. V., & Rönnblom, L. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24686 · Cited by 129
Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis
Xu, W. B., Fazekas, G., Hara, H., & Tabira, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.011 · Cited by 128
The killer's kiss: the many functions of NK cell immunological synapses
Krzewski, K., & Strominger, J. L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.05.006 · Cited by 128
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice
Hodge, D. L., Berthet, C., Coppola, V., Kastenmüller, W., Buschman, M. D., Schaughency, P., Shirota, H., Scarzello, A. J., Subleski, J. J., Anver, M. R., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.003 · Cited by 127
Role of Viruses in the Pathogenesis of Multiple Sclerosis
Tarlinton, R. E., Martynova, E. V., Rizvanov, A. A., Khaiboullina, S. F., & Verma, S. C. (2020) · Viruses · doi:10.3390/v12060643 · Cited by 126
Single Degranulations in NK Cells Can Mediate Target Cell Killing
Gwalani, L. A., & Orange, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701500 · Cited by 123
Involvement of CD8+ T Cells in Multiple Sclerosis
Salou, M., Nicol, B., Garcia, A., & Laplaud, D.-A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00604 · Cited by 122
Features of Memory-Like and PD-1+ Human NK Cell Subsets
Della Chiesa, M., Pesce, S., Muccio, L., Carlomagno, S., Sivori, S., Moretta, A., & Marcenaro, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00351 · Cited by 121
Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A., Moretta, L., & Moretta, A. (2010) · Blood · doi:10.1182/blood-2009-12-256586 · Cited by 118
Ghodke‐Puranik, Y., Joshi, K., Chopra, A., & Patwardhan, B. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-5081-x · Cited by 114
A role for natural killer cells in the immunopathogenesis of multiple sclerosis
Kastrukoff, L. F., Morgan, N., Zecchini, D., White, R., Petkau, A. J., Satoh, J., & Paty, D. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00014-9 · Cited by 112
Williams, F., Meenagh, A., Sleator, C., Cook, D., Fernández-Viña, M., Bowcock, A. M., & Middleton, D. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.04.005 · Cited by 110
Saikali, P., Antel, J. P., Newcombe, J., Chen, Z., Freedman, M. S., Blain, M., Cayrol, R., Prat, A., Hall, J. A., & Arbour, N. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4402-06.2007 · Cited by 110
STATs in NK-Cells: The Good, the Bad, and the Ugly
Gotthardt, D., & Sexl, V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00694 · Cited by 109
IL-2 Induces STAT4 Activation in Primary NK Cells and NK Cell Lines, But Not in T Cells
Wang, K. S., Ritz, J., & Frank, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.299 · Cited by 108
Stewart‐Jones, G. B. E., di Gleria, K., Kollnberger, S., McMichael, A. J., Jones, E. Y., & Bowness, P. (2005) · European Journal of Immunology · doi:10.1002/eji.200425724 · Cited by 105
Deniz, G., Akdiş, M., Aktas, E., Blaser, K., & Akdiş, C. A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<879::aid-immu879>3.0.co;2-2 · Cited by 105
Self-citationGenetics of Natural Killer Cells in Human Health, Disease, and Survival
Parham, P., & Guethlein, L. A. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053149 · Cited by 105
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis
Groß, C. C., Ahmetspahic, D., Ruck, T., Schulte‐Mecklenbeck, A., Schwarte, K., Jörgens, S., Scheu, S., Windhagen, S., Graefe, B., Melzer, N., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000289 · Cited by 103
Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis
Molfetta, R., Quatrini, L., Santoni, A., & Paolini, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081677 · Cited by 103
Hagberg, N., Berggren, O., Leonard, D., Weber, G., Bryceson, Y. T., Alm, G. V., Eloranta, M., & Rönnblom, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003349 · Cited by 102
Kastrukoff, L. F., Lau, A. S., Wee, R., Zecchini, D., White, R., & Paty, D. W. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.001 · Cited by 102
Intrathecal effects of daclizumab treatment of multiple sclerosis
Bielekova, B., Richert, N. D., Herman, M. L., Ohayon, J. M., Waldmann, T. A., McFarland, H. F., Martinꝉ, R., & Blevins, G. (2011) · Neurology · doi:10.1212/wnl.0b013e318239f7ef · Cited by 94
Giovannoni, G., Gold, R., Selmaj, K. W., Havrdová, E., Montalbán, X., Radue, E. W., Stefoski, D., McNeill, M., Amaravadi, L. S., Sweetser, M. T., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70039-0 · Cited by 94
Sepulveda, F. E., Maschalidi, S., Vosshenrich, C. A. J., Garrigue, A., Kurowska, M., Ménasché, G., Fischer, A., Santo, J. P. D., & Basile, G. D. S. (2014) · Blood · doi:10.1182/blood-2014-09-602946 · Cited by 92
The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
Chanvillard, C., Jacolik, R., Infante‐Duarte, C., & Nayak, R. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00063 · Cited by 90
Spada, R., Rojas, J. M., & Barber, D. F. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ru0315-081rr · Cited by 87
Involvement of CD226+ NK Cells in Immunopathogenesis of Systemic Lupus Erythematosus
Huang, Z., Fu, B., Zheng, S. G., Li, X., Sun, R., Tian, Z., & Wei, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000569 · Cited by 87
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. A. (2018) · The Journal of Immunology · doi:10.1093/jimmunol/200.7.2231 · Cited by 87
Aramaki, T., Ida, H., Izumi, Y., Fujikawa, K., Huang, M., Arima, K., Tamai, M., Kamachi, M., Nakamura, H., Kawakami, A., et al. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0160-6 · Cited by 85
Natural killer cells and their receptors in multiple sclerosis.
Kaur, G., Trowsdale, J., & Fugger, L. (2013) · Brain : a journal of neurology · doi:10.1093/brain/aws159 · Cited by 83
Zhu, Y., Huang, B. Y., & Shi, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9980 · Cited by 83
Cited by
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176
Baysac, K., Sun, G., Nakano, H., Schmitz, E. G., Cruz, A. C., Fisher, C., Bailey, A. C., Abbott, J. K., Aldave Becerra, J. C., Allenspach, E. J., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.08.036 · Cited by 63
Biological clock perspective in rheumatoid arthritis
Liu, Q., & Zhang, Y. (2024) · Inflammation · doi:10.1007/s10753-024-02120-4 · Cited by 12
“The crucial role of early innate immune responses in the development of immune-mediated inflammation in general and autoimmunity in particular has received increasing attention [36–38].”
Influential
Metadata
- Authors
- Kucuksezer, U. C., Aktas Cetin, E., Esen, F., Tahrali, I., Akdeniz, N., Gelmez, M. Y., & Deniz, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-25
- Volume
- 12
- Pages
- 622306-622306
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3131639899
- Cited by
- 284
- References
- 283
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.